Next Article 
Infect Immun, January 1998, p. 1-4, Vol. 66, No. 1
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
MINIREVIEW
From Natural Polyreactive Autoantibodies to À La Carte
Monoreactive Antibodies to Infectious Agents: Is It a Small World
after All?
Jean-Pierre
Bouvet1,* and
Guillaume
Dighiero2
Unité d'Immunocytochimie, CNRS URA
1961,1 and
Unité
d'Immunohématologie,2 Institut
Pasteur, 75725 Paris 15, France
 |
INTRODUCTION |
Induction of antibodies (Abs) to
infectious agents requires the help of many different genes involved in
selection and regulation processes. It is thus unlikely that a direct
development of conventional humoral immunity has occurred in the
absence of preliminary simple immune mechanisms. The germinal structure
of the polyreactive Ab system is in agreement with its involvement in
the intermediate steps. Polyreactive auto-Abs have been evidenced in
the serum of all healthy subjects and in myeloma proteins, and a high
frequency of precursor B cells displaying this auto-Ab activity has
been shown elsewhere (13, 14, 20). These data were further
confirmed and expanded by multiple functional and structural studies
(3). Natural Abs predominate early in life and are observed
even in species only distantly related to humans, such as fish and
amphibians (19). They are currently encoded by variable (V)
genes under their germinal configuration (4), and they bind
well-conserved epitopes even from different species.
A feature of major interest is the ability of polyreactive auto-Abs to
bind both self and nonself antigens such as microbial molecules. This
specificity can be associated with the immune defenses against
infection, especially in lower vertebrates. The antimicrobial functions
of natural Abs lead us to discuss the advantages of the further
development of the conventional Ab system in higher vertebrates and to
suggest a scenario involving a successive evolution of these two Ab
systems and their final coexistence as complementary mechanisms
of protection against pathogens.
 |
THE ANTIBODY ANCESTOR |
Both V and constant (C) domains of the heavy (H) and light (L)
chains of immunoglobulins (Igs) are members of a large family of
proteins, which are already present in invertebrates and markedly diverse in vertebrates (23). Because of the genetic distance between vertebrates and invertebrates, most phylogenetic relationships with proteins from these animals remain elusive. However, a soluble protein containing domains of the C type was previously observed in
silkworm larvae, especially during bacterial infections, as reviewed by
Du Pasquier (16). Domains of the V and C types are frequently associated in molecules of the Ig superfamily,
suggesting that the Ab ancestor was formed by two on-line V and C
domains. As a membrane receptor, it could have resembled the CTX
molecule described for Xenopus laevis (17). In a
soluble form, it could have been the covalent homodimer of an unknown
chain and have resembled human Bence-Jones molecules.
Homodimeric L chains are capable of monoreactive
(28) as well as polyreactive (29) Ab
activities, and conversely, most Abs from Camelus
dromedarius comprise only H chains (21). Similar to
the hypothesis of J. Stewart (40), it is likely that the
first molecular recognition by the Ab ancestor was directed against an
endogenous molecule and occurred through a nonimmune mechanism. Indeed,
most natural Abs are reactive with intracellular self-antigens, and
sole specificity could have been of immediate benefit in participating
in the clearance of a degraded or denatured autoantigen.
 |
EMERGENCE OF THE PRIMORDIAL POLYREACTIVE ABS |
From the putative ancestor, addition of the V loops associated
with the presence of J and D segments; heterodimerization between H and
L chains; and duplication of V, J, and D genes gradually extended the
spectrum of specificity of the primordial Ab molecules. A small number
of V genes encoding polyreactive Abs could have been sufficient for
clearance of many autoantigens, provided that these genes were selected
for auto-Ab reactivity. Genetic variations, in terms of auto-Ab
specificity patterns, are observed in mammals and are in favor of such
a selective process (7). Most illustrations of
VH and VL domains represent the hypervariable
regions containing the antigen-binding sites as rigid loops which can
combine with a single epitope. However, interference by the
CH1 domain with the affinity and/or specificity of natural
Abs has demonstrated the possibility of significant plasticity of the
antigen-binding area (36), which is large and mobile enough
for recognition of several unrelated epitopes (5, 27). To
explain the difference between monoreactive and polyreactive Abs, it
has also been speculated that charge distribution within the Ab site
and both length and flexibility of the CDR3 VH region could
account for immunological cross-reactions with diverse and unrelated
substances (26, 30). Finally, the possibility that Abs and
antigens could cooperate to establish better interaction through
conformational changes has also been hypothesized. In contrast to
polyreactive Abs, generally encoded by germinal genes with no (1,
4) or few (24, 30) somatic mutations, conventional
antigen-induced monoreactive Abs are encoded by highly mutated genes,
suggesting that plasticity of the antigen-binding area of germinal
genes is lost during the somatic selection process.
 |
REACTIVITY TO PATHOGENS AS A SECONDARY EFFECT OF POLYREACTIVITY |
The possible autoantigen-driven genetic selection of polyreactive
Abs, described as a "know thyself" process (2), led to a
wide recognition system, which could have progressively involved nonself molecules. This defense mechanism against pathogens could have
occurred as a secondary effect of Ab polyreactivity. The anti-infectious agent defenses were further improved by addition of C
domains and by polymerization, which increased both antigen binding and
effector functions of Abs. Although some polyreactive monoclonal
auto-Abs display a low affinity and have been compared with a weak
nonspecific glue of minor biological significance, other studies have
shown that monoclonal immunoglobulin G (IgG) (41) and
polyclonal secretory IgA (37) polyreactive Abs can display
intrinsic or functional affinity values within the same order of
magnitude as that of monoreactive Abs. Polymerization also allows
immune agglutination, while binding of the different C domains to Fc
receptors gives rise to cellular activation and to transport
mechanisms, extending the role of Abs. Triggering of the complement
cascade also represents a major anti-infectious agent property provided
by the additional C domains.
The primordial Ab system could have remained very simply organized with
a limited number of random somatic mutations, and its regulation could
have required nothing more than a sole balance between constant
secretion and catabolism. Indeed, the multireactivity of the whole set
of polyreactive Abs allows the absence of somatic induction-selection
mechanisms. This primordial system could provide self-antigen clearance
as well as basic protection against commensal organisms and against low
inocula of pathogens. The Abs were also transported across epithelial
cells towards the digestive lumen, as observed for primitive
vertebrates (18). Such an economical system must have been
well adapted to the low energy requirements of cold-blooded animals and
to their high fecundity, preserving a species from complete extinction
in case of immune failure against a pathogen.
 |
TOWARDS MODERN DELUXE ABS |
The high energy burden of mammals, their lower fecundity, and a
possible adaptation of pathogens to the natural Ab spectrum have led to
improvement of Ab efficiency by production of molecules designed to
react solely with the corresponding antigen. Because the immune
response with these à la carte (especially designed) Abs is
delayed, the primordial Ab system has persisted as a basic mechanism of
immunity in the higher vertebrates.
Polyreactivity of the primordial molecules does not imply that all
epitopes can be recognized. Indeed, immunogenic epitopes of tubulin are
not detected by human polyreactive Abs (31). Similarly, we
have failed to detect significant levels of Abs to different bacterial
adhesins among natural Abs. Antigens which are not detected by the
species-specific set of polyreactive Abs are certainly of importance
for the strategy of pathogens and may have been selected by
microorganisms as factors in pathogenicity. This antigenic adaptation
of virulence-associated molecules may thus have triggered the
development of a novel type of immunity raising monoreactive Abs to
these pathogenic molecules. This may be the reason why polyreactive Abs
do not generally interfere with anti-infectious agent serodiagnostic
assays. In addition, the spectrum of natural Abs is an individual
characteristic with a lifelong stability. Some differences have been
observed between newborn and old mice (26), and a global
increase of natural Abs during parasitic infections has been reported
elsewhere (42), but these changes are either slow or
unrelated to a specific immune response. In contrast, the
antigen-driven response is progressively adapted to the pathogen in
terms of specificity and of increased specific activity and affinity.
Natural Abs are thus designed for immune prevention and urgent
protection, whereas antigen-induced Abs are specifically designed for
recovery from damages and for immune memory against a further
challenge.
Although a weak antigen-driven immune response can be observed in
primitive vertebrates, the humoral immunity of these animals involves
primarily polyreactive Abs (19). The branching of a monoreactive system may have preceded divergence between cold-blooded and evolved vertebrates or occurred later during their respective evolutions. In mice, a quantitatively minor set of B cells bearing the
CD-5 marker (B-1 cells) has been proposed to be a major source of
natural Abs, as reviewed by Murakami and Honjo (34).
However, a large proportion of polyreactive Abs is synthesized by
CD5
B-2 cells (12).
The respective roles of polyreactive and of monoreactive secretory IgA
in the human digestive tract are easier to elucidate. These molecules
are locally secreted in the mucosa or passively received from distant
areas, such as from salivary glands (in adults) and from mammary glands
(in newborns) (11, 33). The locally synthesized molecules
serve to clear the lamina propria (25) and epithelial cells
(32) of local pathogens during polymeric Ig
receptor-mediated transport towards the lumen. This protective effect
is delayed and dependent on an antigen-induced response initiated in
Peyer's patches containing virtually no B-1 cells. In contrast,
luminal secretory IgA, which comprises a large proportion of
polyreactive Abs, continuously clears the mucosal surface of the
pathogens in order to prevent their entry into the body. It seems
therefore that secretory IgA-associated digestive immunity represents a
good model of the complementary roles of polyreactive and monoreactive
Abs (Fig. 1).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
A proposed scenario of the evolution of humoral immunity
from primordial natural Abs. These molecules could have been
polyreactive to intracellular autoantigens, but their weak avidity
impaired their efficiency. The auto-Ab specificity could have been
the major selection force increasing blood and tissue clearance. In
secretions, modern natural Abs impair absorption of insufficiently
degraded autoantigens, preventing induction of autoimmunity.
Similarly, the preimmune reactivity to microorganisms led to
the first-barrier phenomenon, but its limitations could have
necessitated monospecific Abs to microbial pathogenic factors. A
soluble coreceptor molecule is envisioned, allowing a potentiation of
Abs similar to that of the gut protein Fv towards degraded secretory
Abs. The V-segment binding of microbial B-cell superantigens could be
an adaptation of pathogens to induce apoptosis of corresponding B
cells.
|
|
 |
VH FAMILIES AND B-CELL SUPERANTIGENS |
Binding of membrane Ig of the B-cell receptor is an important
event in B-cell activation and selection. It has long been assumed that
only the hypervariable regions of the Ab are involved in ligand
binding. However, since the initial description of superantigens, accumulating evidence has suggested that an additional mode of interaction can occur, one whereby these molecules preferentially bind
Ig structures encoded by a given V-gene segment, a V-gene family, or
even a V-gene family clan (43). This interaction requires
contributions from structures located in the solvent-exposed regions of
FR1 and FR3 outside the conventional antigen-binding site (22,
38). Owing to this binding mechanism, the frequency of membrane
and soluble Igs recognized by superantigens largely exceeds that of Abs
to classical antigens.
A current opinion is that microbial superantigens are involved in
pathogenicity by nonimmune stimulation of a high percentage of B cells,
leading to cellular apoptosis which impairs the corresponding immune
defenses. This would be the case for, namely, staphylococcal protein A
(38); human immunodeficiency virus type 1 gp120
(6), which can bind VH3-positive Igs;
staphylococcal enterotoxin D (VH4 specific)
(15); and protein L from Peptostreptococcus
magnus (V
specific) (35). The additional description
of an endogenous Ig superantigen, called protein Fv (pFv)
(10), has suggested a role for the recognized Ig structure
itself. Indeed, pFv displays a VH-binding repertoire much
larger than that of the reference protein A superantigen
(39). It can bind not only human
VH3+ Igs but also clan 3+ Igs from
most mammals and Igs from inferior vertebrates, including the primitive
fish sturgeon (8). Hence, the recognized structure has been
highly conserved during evolution. A fascinating hypothesis is that the
first Abs developed a site of recognition of a soluble coreceptor
related to pFv. The primitive role of this pFv-binding site could have
been to amplify the effector functions of small-sized polyreactive Abs.
This is suggested by the findings for human gut secretions in which pFv
binds cleavage fragments of secretory IgA to form large nonimmune
complexes of 800 to 1,800 kDa (9). These complexes are
called immune fortresses because they exhibit high agglutination
activities for viruses and bacteria and thus play a major role in
defenses against infectious agents.
 |
CONCLUSION |
According to recent data, the modern-type monoreactive Abs
resulting from antigen-driven selection are included in a deluxe immune
system which may have branched off from a putative primordial Ab system
of polyreactive molecules. The primordial system would have gradually
extended its role from solely clearance of a restricted number of
autoantigens by the first Abs to the recognition of a large number of
both self and nonself epitopes. A second site of recognition, located
in the framework, has developed to amplify Ab activity of these
germinal molecules. All these mechanisms still coexist in humans. The
polyreactive Ab system seems to prevent autoimmunity and the entry of
large numbers of microorganisms. It likely provides first-aid immune
protection but fails to protect against the pathogens which have
selected virulence-associated molecules poorly recognized by natural
Abs. Modern Abs are involved in à la carte immunity to the
virulence factors. After boosting, both the level of these induced Abs
and their affinity for the corresponding antigens gradually increase,
while an immune memory develops. The second site of recognition allows
pFv to bind natural Abs in the gut lumen where their functions are
restored and even largely increased. As a possible side effect,
adaptation of some microorganisms to this framework site has led to the
occurrence of pathogenic B-cell superantigens interfering with the
VH family-associated immune response.
 |
ACKNOWLEDGMENTS |
We thank S. Iscaki for critical review of the manuscript and A. Berneman for his help in the design of Fig. 1.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unité
d'Immunocytochimie, Institut Pasteur, 25 rue du Dr. Roux,
75724 Paris Cedex 15, France. Phone: (33) 1 45 68 82 56. Fax: (33) 1 45 68 86 39. E-mail: jpbouvet{at}pasteur.fr.
Editor: J. R. McGhee
 |
REFERENCES |
| 1.
|
Adib-Conquy, M.,
M. Gilbert,
C. Christodoulo, and S. Avrameas.
1994.
Reactivity and structure of a mouse anti-F(ab')2 IgM. Comparison of its variable region sequences with those of a structurally close polyreactive natural IgM.
Mol. Immunol.
31:555-562[Medline].
|
| 2.
|
Avrameas, S.
1991.
Natural autoantibodies. From horror autotoxicus to gnothi seauton.
Immunol. Today
12:154-159[Medline].
|
| 3.
|
Avrameas, S., and T. Ternynck.
1995.
Natural autoantibodies: the other side of the immune system.
Res. Immunol.
146:235-248[Medline].
|
| 4.
|
Baccala, R.,
T. V. Quang,
M. Gilbert,
T. Ternynck, and S. Avrameas.
1989.
Two murine natural autoantibodies are encoded by nonmutated germ-line genes.
Proc. Natl. Acad. Sci. USA
86:4624-4628[Abstract/Free Full Text].
|
| 5.
|
Bentley, G. A.,
G. Boulot,
M. M. Riottot, and R. J. Poljak.
1990.
Three-dimensional structure of an idiotope-anti-idiotope complex.
Nature
348:254-260[Medline].
|
| 6.
|
Berberian, L.,
L. Goodglick,
T. J. Kipps, and J. Braun.
1993.
Immunoglobulin VH3 gene products for HIV gp120.
Science
261:1588-1591[Abstract/Free Full Text].
|
| 7.
|
Berneman, A.,
T. Ternynck, and S. Avrameas.
1992.
Natural mouse IgG reacts with self antigens including molecules involved in the immune response.
Eur. J. Immunol.
22:625-633[Medline].
|
| 8.
|
Bouvet, J. P.,
R. Pirès,
J. Charlemagne,
J. Pillot, and S. Iscaki.
1991.
Non-immune binding of human protein Fv to immunoglobulins of various mammalian and non-mammalian species.
Scand. J. Immunol.
34:491-496[Medline].
|
| 9.
|
Bouvet, J. P.,
R. Pirès,
S. Iscaki, and J. Pillot.
1993.
Nonimmune macromolecular complexes of Ig in human gut lumen: probable enhancement of antibody functions.
J. Immunol.
151:2562-2571[Abstract].
|
| 10.
|
Bouvet, J. P.,
R. Pirès,
F. Lunel-Fabiani,
B. Crescenzo-Chaigne,
P. Maillard,
D. Valla,
P. Opolon, and J. Pillot.
1990.
Protein F: a novel F(ab) binding factor, present in normal liver, and largely released in the digestive tract during hepatitis.
J. Immunol.
145:1176-1180[Abstract].
|
| 11.
|
Brandtzaeg, P.
1995.
Molecular and cellular aspects of the secretory immunoglobulin system.
Acta Pathol. Microbiol. Immunol. Scand.
103:1-19.
|
| 12.
|
Chen, Z. J.,
J. Wheeler, and A. L. Notkins.
1995.
Antigen-binding B cells and polyreactive antibodies.
Eur. J. Immunol.
25:579-586[Medline].
|
| 13.
|
Dighiero, G.,
B. Guilbert, and S. Avrameas.
1982.
Naturally occurring antibodies against nine common antigens in human sera. II. High incidence of monoclonal Ig exhibiting antibody activity against actin and tubulin and sharing antibody specificities with natural antibodies.
J. Immunol.
128:2788-2792[Medline].
|
| 14.
|
Dighiero, G.,
P. Lymberi,
J. C. Mazié,
S. Rouyre,
G. S. Butler-Browne,
R. G. Whalen, and S. Avrameas.
1983.
Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens.
J. Immunol.
131:2267-2272[Abstract].
|
| 15.
|
Domiati-Saad, R.,
J. F. Attrep,
H. P. Brezinschek,
A. Cerrie,
D. R. Karp, and P. E. Lipsky.
1996.
Staphylococcal enterotoxin D functions as a human B cell superantigen by rescuing VH4-expressing B cells from apoptosis.
J. Immunol.
156:3608-3620[Abstract].
|
| 16.
|
Du Pasquier, L.
1993.
Evolution of the immune system, p. 199-233. In
W. E. Paul (ed.), Fundamental immunology.
Raven Press, New York, N.Y.
|
| 17.
|
Du Pasquier, L., and I. Chrétien.
1996.
CTX, a new lymphocyte receptor in Xenopus, and the early evolution of Ig domains.
Res. Immunol.
147:218-226[Medline].
|
| 18.
|
Fellah, J. S.,
S. Iscaki,
J. P. Vaerman, and J. Charlemagne.
1992.
Transient developmental expression of IgY and secretory component like protein in the gut of the axolotl (Ambystoma mexicanum).
Dev. Immunol.
2:181-190[Medline].
|
| 19.
|
Gonzalez, R.,
J. Charlemagne,
W. Mahana, and S. Avrameas.
1988.
Specificity of natural serum antibodies present in phylogenetically distinct fish species.
Immunology
63:31-36[Medline].
|
| 20.
|
Guilbert, B.,
G. Dighiero, and S. Avrameas.
1982.
Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization.
J. Immunol.
128:2779-2787[Medline].
|
| 21.
|
Hamers-Casterman, C.,
T. Atarhouch,
S. Muydermans,
G. Robinson,
C. Hamers,
E. Bayanasonga,
N. Bendahman, and R. Hamers.
1993.
Naturally occurring antibodies devoid of light chains.
Nature
363:446-448[Medline].
|
| 22.
|
Hillson, J. L.,
N. S. Karr,
I. R. Oppliger,
M. Mannik, and E. H. Sasso.
1993.
The structural basis of germline-encoded VH3 immunoglobulin binding of staphylococcal protein A.
J. Exp. Med.
178:331-336[Abstract/Free Full Text].
|
| 23.
|
Huncapiller, T., and L. Hood.
1989.
Diversity of the immunoglobulin gene superfamily.
Adv. Immunol.
44:1-63[Medline].
|
| 24.
|
Ikematsu, H.,
M. T. Kasaian,
E. W. Schettino, and P. Casali.
1993.
Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection.
J. Immunol.
151:3604-3616[Abstract].
|
| 25.
|
Kaetzel, C. S.,
J. K. Robinson,
K. R. Chantalacharuvu,
J. P. Vaerman, and M. E. Lamm.
1991.
The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA.
Proc. Natl. Acad. Sci. USA
88:8796-8800[Abstract/Free Full Text].
|
| 26.
|
Lacroix-Desmazes, S.,
L. Mouthon,
A. Coutinho, and M. Kazatchkine.
1995.
Analysis of the natural human IgG antibody repertoire: life-long stability of reactivities towards self antigens contrasts with age-dependent diversification of reactivities against bacterial antigens.
Eur. J. Immunol.
25:2598-2604[Medline].
|
| 27.
|
Lescar, L. J.,
M. Pellegrini,
H. Souchon,
D. Tello,
R. J. Poljak,
N. Peterson,
M. Greene, and P. M. Alzari.
1995.
Crystal structure of a cross-reaction complex between Fab F9.13.7 and guinea fowl lysozyme.
J. Biol. Chem.
270:18067-18073[Abstract/Free Full Text].
|
| 28.
|
Mahana, W.,
F. Jacquemart, and M. Ermonval.
1994.
A murine monoclonal multireactive immunoglobulin kappa light chain.
Scand. J. Immunol.
39:107-110[Medline].
|
| 29.
|
Mangalo, R.,
S. Iscaki, and M. Raynaud.
1966.
Présence d'activité anticorps dans des préparations de chaînes légères.
C. R. Acad. Sci. (Paris)
263D:204-207.
|
| 30.
|
Martin, T.,
R. Crouzier,
J. C. Weber,
T. J. Kipps, and J. L. Pasquali.
1994.
Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementary-determining region of the antibody heavy chain.
J. Immunol.
152:5988-5996[Abstract].
|
| 31.
|
Matthes, T.,
A. Wolff,
P. Soubiran,
F. Gros, and G. Dighiero.
1988.
Antitubulin antibodies. II. Natural autoantibodies and induced antibodies recognize different epitopes on the tubulin molecule.
J. Immunol.
141:3135-3141[Abstract].
|
| 32.
|
Mazanec, M. B.,
C. S. Kaetzel,
M. E. Lamm,
D. Fletcher, and J. G. Nedrud.
1992.
Intracellular neutralization of virus by immunoglobulin A antibodies.
Proc. Natl. Acad. Sci. USA
89:6901-6905[Abstract/Free Full Text].
|
| 33.
|
McGhee, J. R., and H. Kiyono.
1993.
New perspectives to vaccine development: mucosal immunity to infections.
Infect. Agents Dis.
2:55-73[Medline].
|
| 34.
|
Murakami, M., and T. Honjo.
1995.
Involvement of B-1 cells in mucosal immunity and autoimmunity.
Immunol. Today
16:534-538[Medline].
|
| 35.
|
Nilson, B. H. K.,
A. Solomon,
L. Björck, and B. Åkerström.
1992.
Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain.
J. Biol. Chem.
267:2234-2239[Abstract/Free Full Text].
|
| 36.
|
Pritsch, O.,
G. Hudry-Clergeon,
M. Buckle,
Y. Pétillot,
J. P. Bouvet,
J. Gagnon, and G. Dighiero.
1996.
Can immunoglobulin CH1 constant domain modulate antigen binding affinity of antibodies?
J. Clin. Invest.
98:2235-2243[Medline].
|
| 37.
|
Quan, C.,
A. Berneman,
R. Pirès,
S. Avrameas, and J. P. Bouvet.
1997.
Natural polyreactive secretory immunoglobulin A autoantibodies as a possible immune barrier in humans.
Infect. Immun.
65:3997-4004[Abstract].
|
| 38.
|
Silverman, G. J.
1992.
Human antibody responses to bacterial antigens: studies of a model conventional antigen and a proposed model B cell superantigen.
Int. Rev. Immunol.
9:57-78[Medline].
|
| 39.
|
Silverman, G. J.,
R. Pirès, and J. P. Bouvet.
1996.
An endogenous sialoprotein and a bacterial superantigen compete in their VH family-specific binding interactions with human Igs.
J. Immunol.
157:496-502.
|
| 40.
|
Stewart, J.
1992.
Immunoglobulin did not arise in evolution to fight infection.
Immunol. Today
13:396-399[Medline].
|
| 41.
|
Ternynck, T., and S. Avrameas.
1986.
Murine natural monoclonal autoantibodies: a study of their polyspecificities and affinities.
Immunol. Rev.
94:99-112[Medline].
|
| 42.
|
Ternynck, T.,
P. B. Falanga,
C. Unterkisher,
J. Grégoire,
L. Pereira da Silva, and S. Avrameas.
1991.
Induction of high levels of IgG autoantibodies in mice infected with Plasmodium chabaudii.
Int. Immunol.
3:29-37[Abstract/Free Full Text].
|
| 43.
|
Zouali, M.
1995.
B-cell superantigens: implications for selection of the human antibody repertoire.
Immunol. Today
16:399-405[Medline].
|
Infect Immun, January 1998, p. 1-4, Vol. 66, No. 1
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wijburg, O. L.C., Uren, T. K., Simpfendorfer, K., Johansen, F.-E., Brandtzaeg, P., Strugnell, R. A.
(2006). Innate secretory antibodies protect against natural Salmonella typhimurium infection. JEM
203: 21-26
[Abstract]
[Full Text]
-
Haynes, B. F., Fleming, J., St. Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., Ortel, T. L., Liao, H.-X., Alam, S. M.
(2005). Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies. Science
308: 1906-1908
[Abstract]
[Full Text]
-
Warren, D. J., Bjerner, J., Paus, E., Bormer, O. P., Nustad, K.
(2005). Use of an In Vivo Biotinylated Single-Chain Antibody as Capture Reagent in an Immunometric Assay to Decrease the Incidence of Interference from Heterophilic Antibodies. Clin. Chem.
51: 830-838
[Abstract]
[Full Text]
-
Pilette, C., Durham, S. R., Vaerman, J.-P., Sibille, Y.
(2004). Mucosal Immunity in Asthma and Chronic Obstructive Pulmonary Disease: A Role for Immunoglobulin A?. Proc Am Thorac Soc
1: 125-135
[Abstract]
[Full Text]
-
Jonsson, S., Vidarsson, G., Valdimarsson, H., Schiffman, G., Schneerson, R., Jonsdottir, I.
(2002). Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine. Eur Respir J
20: 813-818
[Abstract]
[Full Text]
-
Young, S. L., O'Donnell, M. A., Buchan, G. S.
(2002). IL-2-secreting recombinant bacillus Calmette Guerin can overcome a Type 2 immune response and corticosteroid-induced immunosuppression to elicit a Type 1 immune response. Int Immunol
14: 793-800
[Abstract]
[Full Text]
-
Pilette, C., Ouadrhiri, Y., Godding, V., Vaerman, J-P., Sibille, Y.
(2001). Lung mucosal immunity: immunoglobulin-A revisited. Eur Respir J
18: 571-588
[Abstract]
[Full Text]
-
Attaelmannan, M., Levinson, S. S.
(2000). Understanding and Identifying Monoclonal Gammopathies. Clin. Chem.
46: 1230-1238
[Abstract]
[Full Text]
-
Bouvet, J.-P., Fischetti, V. A.
(1999). Diversity of Antibody-Mediated Immunity at the Mucosal Barrier. Infect. Immun.
67: 2687-2691
[Full Text]
-
Kaplan, I. V., Levinson, S. S.
(1999). When Is a Heterophile Antibody Not a Heterophile Antibody? When It Is an Antibody against a Specific Immunogen. Clin. Chem.
45: 616-618
[Abstract]
[Full Text]
-
Baumgarth, N., Herman, O. C., Jager, G. C., Brown, L., Herzenberg, L. A., Herzenberg, L. A.
(1999). Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc. Natl. Acad. Sci. USA
96: 2250-2255
[Abstract]
[Full Text]
-
Messmer, B. T., Sullivan, J. J., Chiorazzi, N., Rodman, T. C., Thaler, D. S.
(1999). Two Human Neonatal IgM Antibodies Encoded by Different Variable-Region Genes Bind the Same Linear Peptide: Evidence for a Stereotyped Repertoire of Epitope Recognition. J. Immunol.
162: 2184-2192
[Abstract]
[Full Text]
-
Patella, V., Giuliano, A., Bouvet, J.-P., Marone, G.
(1998). Endogenous Superallergen Protein Fv Induces IL-4 Secretion from Human Fc{epsilon}RI+ Cells Through Interaction with the VH3 Region of IgE. J. Immunol.
161: 5647-5655
[Abstract]
[Full Text]
-
Adderson, E. E., Wilson, P. M., Cunningham, M. W., Shackelford, P. G.
(1998). Haemophilus influenzae Type b Polysaccharides-Protein Conjugate Vaccine Elicits a More Diverse Antibody Repertoire in Infants Than in Adults. J. Immunol.
161: 4177-4182
[Abstract]
[Full Text]